Atherosclerosis imaging as a benchmark in the development of novel cardiovasular drugs

Raphael Duivenvoorden, Aart J. Nederveen, Eric de Groot, John J. P. Kastelein

Research output: Contribution to journalReview articleAcademicpeer-review

26 Citations (Scopus)

Abstract

Arterial imaging may provide the first glimpse of the efficacy or failure of a novel strategy to combat atherosclerosis. These findings suggest that vascular imaging could be employed to probe whether or not a large m mortality endpoint study should be the next step in a clinical development program
Original languageEnglish
Pages (from-to)613-621
JournalCurrent opinion in lipidology
Volume18
Issue number6
DOIs
Publication statusPublished - 2007

Cite this